293 related articles for article (PubMed ID: 36012306)
21. Characterization of a mutated KCNJ5 gene, G387R, in unilateral primary aldosteronism.
Chueh JS; Peng KY; Wu VC; Wang SM; Chan CK; Chen YM; Ke YY; Pan CY; Liao HW
J Mol Endocrinol; 2021 Sep; 67(4):203-215. PubMed ID: 34463641
[TBL] [Abstract][Full Text] [Related]
22. Macrolides Blunt Aldosterone Biosynthesis: A Proof-of-Concept Study in
Caroccia B; Prisco S; Seccia TM; Piazza M; Maiolino G; Rossi GP
Hypertension; 2017 Dec; 70(6):1238-1242. PubMed ID: 28993452
[TBL] [Abstract][Full Text] [Related]
23. Case Report: Nodule Development From Subcapsular Aldosterone-Producing Cell Clusters Causes Hyperaldosteronism.
Nishimoto K; Seki T; Kurihara I; Yokota K; Omura M; Nishikawa T; Shibata H; Kosaka T; Oya M; Suematsu M; Mukai K
J Clin Endocrinol Metab; 2016 Jan; 101(1):6-9. PubMed ID: 26580238
[TBL] [Abstract][Full Text] [Related]
24. KCNJ5 Somatic Mutation Is Associated With Higher Aortic Wall Thickness and Less Calcification in Patients With Aldosterone-Producing Adenoma.
Lee BC; Kang VJ; Pan CT; Huang JZ; Lin YL; Chang YY; Tsai CH; Chou CH; Chen ZW; Liao CW; Chiu YW; Wu VC; Hung CS; Chang CC; Lin YH
Front Endocrinol (Lausanne); 2022; 13():830130. PubMed ID: 35311227
[TBL] [Abstract][Full Text] [Related]
25. Overview of aldosterone-related genetic syndromes and recent advances.
Zennaro MC; Fernandes-Rosa FL; Boulkroun S
Curr Opin Endocrinol Diabetes Obes; 2018 Jun; 25(3):147-154. PubMed ID: 29432258
[TBL] [Abstract][Full Text] [Related]
26. Somatic and inherited mutations in primary aldosteronism.
Fernandes-Rosa FL; Boulkroun S; Zennaro MC
J Mol Endocrinol; 2017 Jul; 59(1):R47-R63. PubMed ID: 28400483
[TBL] [Abstract][Full Text] [Related]
27. KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma.
Kitamoto T; Omura M; Suematsu S; Saito J; Nishikawa T
J Hypertens; 2018 Mar; 36(3):619-627. PubMed ID: 29016532
[TBL] [Abstract][Full Text] [Related]
28. Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance.
Cheng CJ; Sung CC; Wu ST; Lin YC; Sytwu HK; Huang CL; Lin SH
J Clin Endocrinol Metab; 2015 Jan; 100(1):E155-63. PubMed ID: 25347571
[TBL] [Abstract][Full Text] [Related]
29. Tumor Cell Subtypes Based on the Intracellular Hormonal Activity in KCNJ5-Mutated Aldosterone-Producing Adenoma.
Yamazaki Y; Omata K; Tezuka Y; Ono Y; Morimoto R; Adachi Y; Ise K; Nakamura Y; Gomez-Sanchez CE; Shibahara Y; Kitamoto T; Nishikawa T; Ito S; Satoh F; Sasano H
Hypertension; 2018 Sep; 72(3):632-640. PubMed ID: 30354756
[TBL] [Abstract][Full Text] [Related]
30. Different Somatic Mutations in Multinodular Adrenals With Aldosterone-Producing Adenoma.
Fernandes-Rosa FL; Giscos-Douriez I; Amar L; Gomez-Sanchez CE; Meatchi T; Boulkroun S; Zennaro MC
Hypertension; 2015 Nov; 66(5):1014-22. PubMed ID: 26351028
[TBL] [Abstract][Full Text] [Related]
31. A Novel Somatic Deletion Mutation of ATP2B3 in Aldosterone-Producing Adenoma.
Murakami M; Yoshimoto T; Minami I; Bouchi R; Tsuchiya K; Hashimoto K; Izumiyama H; Fujii Y; Endo T; Akashi T; Nishimoto K; Mukai K; Kihara K; Ogawa Y
Endocr Pathol; 2015 Dec; 26(4):328-33. PubMed ID: 26481629
[TBL] [Abstract][Full Text] [Related]
32. Hypomethylation of CYP11B2 in Aldosterone-Producing Adenoma.
Yoshii Y; Oki K; Gomez-Sanchez CE; Ohno H; Itcho K; Kobuke K; Yoneda M
Hypertension; 2016 Dec; 68(6):1432-1437. PubMed ID: 27754862
[TBL] [Abstract][Full Text] [Related]
33. Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White Americans.
Nanba K; Omata K; Else T; Beck PCC; Nanba AT; Turcu AF; Miller BS; Giordano TJ; Tomlins SA; Rainey WE
J Clin Endocrinol Metab; 2018 Oct; 103(10):3869-3876. PubMed ID: 30085035
[TBL] [Abstract][Full Text] [Related]
34. Molecular Heterogeneity in Aldosterone-Producing Adenomas.
Nanba K; Chen AX; Omata K; Vinco M; Giordano TJ; Else T; Hammer GD; Tomlins SA; Rainey WE
J Clin Endocrinol Metab; 2016 Mar; 101(3):999-1007. PubMed ID: 26765578
[TBL] [Abstract][Full Text] [Related]
35. Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production.
Hattangady NG; Karashima S; Yuan L; Ponce-Balbuena D; Jalife J; Gomez-Sanchez CE; Auchus RJ; Rainey WE; Else T
J Mol Endocrinol; 2016 Jul; 57(1):1-11. PubMed ID: 27099398
[TBL] [Abstract][Full Text] [Related]
36. Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism.
Maiolino G; Ceolotto G; Battistel M; Barbiero G; Cesari M; Amar L; Caroccia B; Padrini R; Azizi M; Rossi GP
Blood Press; 2018 Aug; 27(4):200-205. PubMed ID: 29409357
[TBL] [Abstract][Full Text] [Related]
37. Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.
Monticone S; Hattangady NG; Nishimoto K; Mantero F; Rubin B; Cicala MV; Pezzani R; Auchus RJ; Ghayee HK; Shibata H; Kurihara I; Williams TA; Giri JG; Bollag RJ; Edwards MA; Isales CM; Rainey WE
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1567-72. PubMed ID: 22628608
[TBL] [Abstract][Full Text] [Related]
38. Aldosterone-producing adenoma-harbouring KCNJ5 mutations is associated with lower prevalence of metabolic disorders and abdominal obesity.
Chen KM; Chang YL; Wu TH; Lee BC; Chen PT; Liu KL; Hong JS; Chang CC; Wu VC; Lin YH;
J Hypertens; 2021 Dec; 39(12):2353-2360. PubMed ID: 34313632
[TBL] [Abstract][Full Text] [Related]
39. KCNJ5 Mutation Contributes to Complete Clinical Success in Aldosterone-Producing Adenoma: A Study From a Single Center.
Zhang C; Wu L; Jiang L; Su T; Zhou W; Zhong X; Xie J; Sun F; Zhu Y; Jiang Y; Wang W
Endocr Pract; 2021 Jul; 27(7):736-742. PubMed ID: 33678553
[TBL] [Abstract][Full Text] [Related]
40. Voltage-gated calcium channels in the human adrenal and primary aldosteronism.
Felizola SJ; Maekawa T; Nakamura Y; Satoh F; Ono Y; Kikuchi K; Aritomi S; Ikeda K; Yoshimura M; Tojo K; Sasano H
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():410-6. PubMed ID: 25151951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
